News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Investor (World)
Celon Pharma's Warsaw Stock Exchange IPO 10/21/2016
Horizon Pharma (HZNP) Announces Pricing Of Private Offering Of Senior Notes 10/20/2016
Karolinska Development AB Company Dilaforette To Change Name To Modus Therapeutics And Announces Intention To Conduct An Initial Public Offering 10/20/2016
Concordia (CXR.TO) Announces Closing Of Senior Notes Offering And Appoints Allan Oberman To Board Of Directors 10/13/2016
Horizon Pharma (HZNP) Announces Proposed Private Offering Of Senior Notes And Intention To Borrow Incremental Term Loans Under Its Existing Senior Secured Credit Facility 10/13/2016
BioSTAR Announces Execution Of Agreement For $1.91 Million Registered Direct Offering Of Shares Of Common Stock And Warrants 10/12/2016
Nordic Nanovector: Extraordinary General Meeting Held 10/12/2016
MMJ PhytoTech Ltd Raises $4 Million In An Over-Subscribed Share Placement 10/11/2016
Concordia International Announces Offering Of Senior Notes 10/6/2016
Advanced Accelerator Applications Announces Pricing Of $150 Million Public Offering Of American Depositary Shares 10/6/2016
Advanced Accelerator Applications Announces Proposed Public Offering Of American Depositary Shares 10/5/2016
Siegfried Increases Hybrid Bond To CHF 160 Million 10/4/2016
MMJ PhytoTech Ltd Full Year Statutory Accounts 10/3/2016
Acorda (ACOR) Gains Title To Biotie Shares And The Shares Will Delist 9/30/2016
CXR Biosciences To Expand Its Mechanistic Toxicology Services Following Scientific Advisory Board Endorsement 9/30/2016
3 Biotech Stocks to Steer Clear of 9/29/2016
GM&C Life Sciences Fund Invests In SwabTech 9/29/2016
MMJ PhytoTech Ltd Unlocking Near-Term Value And Optimising Assets For Growth 9/28/2016
Two Promising Biotech Stocks Under $5, and One to Avoid Like the Plague 9/27/2016
Arbitral Tribunal Confirmed Acorda (ACOR)'s Redemption Right Regarding Biotie Shares And Biotie Shares Trading Has Been Terminated 9/26/2016
Nolato AB ( NOLA-B.ST): Acquisition Conference Call Today At 3.30 PM CET 9/26/2016
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 9/23/2016
China Cord Blood To Hold Annual General Meeting In Hong Kong On December 9, 2016 9/23/2016
Orexo (ORXOF): Issue And Repurchase Of Class C Shares 9/22/2016
How Medtronic (MDT), Now Based in Ireland, Still Reaps U.S. Benefits 9/21/2016
GM&C Life Sciences Fund Makes Further Seed Investments 9/20/2016
Company Profile For MOF Technologies 9/16/2016
Tiziana Life Sciences Plc: Confirmation of Capital Reduction 9/15/2016
Resverlogix (RVX.TO) Announces Filing Of Quarterly Financial Statements And Management's Discussion & Analysis 9/15/2016
Lachesis Biosciences ASX Initial Public Offer - Prospectus And Application 9/15/2016
Good or Bad? Pharma Bro Thinks Jazz Pharma (JAZZ) Could be Worth $20 Billion, Calls Mast Therapeutics (MSTX) 'Worthless' 9/14/2016
Novogen Limited (NVGN) Release: Conversion Of Convertible Notes 9/14/2016
Perrigo (PRGO) Acknowledges Receipt Of Letter From Starboard Value LP 9/13/2016
Venture Capital: Evonik Industries Invests In Irish Medical Device Company Vivasure Medical 9/8/2016
Juno (JUNO), Kite Pharma (KITE) Fall After Novartis AG (NVS) Dissolves CAR-T Unit 9/6/2016
Shire (SHPG): U.S. Securities And Exchange Commission Filings 9/6/2016
Faron Pharmaceuticals Ltd. Release: Interim Results 2016: Progress Continued In Traumakine Phase III And With Clevegen Indications Extended 9/6/2016
Fosun International Ltd. Will Use Healthcare Assets to Create Liquidity 9/1/2016
Genmab A/S (GEN.CO)'s Total Number Of Voting Rights And Total Share Capital 9/1/2016
Annual General Meeting Of AddLife AB 1 September 2016 9/1/2016
Elekta: Interim Report May – July 2016/17 9/1/2016
New Number Of Shares And Votes In Sobi 8/31/2016
Nordic Nanovector - Financial Calendar 8/31/2016
Bulletin From The Extraordinary General Meeting In MEDA (Publ) 8/25/2016
Bulletin From The Extraordinary General Meeting In MEDA 8/25/2016
Sophiris Bio (SPHS) Announces Proposed Public Offering Of Common Shares And Warrants 8/23/2016
Sophiris Bio (SPHS) Prices Public Offering Of Common Shares And Warrants 8/23/2016
Concordia International Corp. Issues Statement On Sale Of Company Stock 8/23/2016
Endo International (ENDP)'s President And CEO Adopts 10b5-1 Trading Plan 8/19/2016
Tiziana Life Sciences Plc: Change Of Registered Office 8/19/2016
Cardiome Pharma Corp. (COM.TO) Announces Recent Insider Purchases 8/16/2016
Ascendis Pharma A/S Announces R&D Update To Review Expanded Pipeline And Long-Term Strategic Outlook 8/16/2016
Amarin (AMRN) Announces Underwriters’ Exercise of Option to Purchase Additional American Depositary Shares 8/15/2016
Medtronic (MDT) Completes $20 Million Second Tranche Investment in Mazor Robotics 8/15/2016
QIAGEN N.V. (QGEN) Announces Plans to Return Approximately $250 Million to Shareholders Via Synthetic Share Repurchase Proposal 8/15/2016
Vietnam Drug Stocks Surging As Foreigners Covet Booming Industry 8/12/2016
Suven Life Sciences Ltd’s Income At Rs. 1377 Mn; PAT At Rs. 326 Mn For The 1st Quarter Ended June 2016 8/10/2016
Noxopharm Commences Trading On ASX 8/9/2016
Bactiguard AB: Extended Maturity For Credit Facility 8/9/2016
Noxopharm To List On ASX On Tuesday, 9th August 2016 8/8/2016
Sobi’s CEO Divests A Portion Of Shares 8/8/2016
Delisting Of Meda Aktiebolag 8/8/2016
Novo Nordisk A/S (NVO) Plummets Amid Pricing Challenges in U.S. Market 8/5/2016
MEDA: Notice To Noteholders Regarding Change Of Control 8/5/2016
Allergan (AGN) Completes Divestiture Of Global Generics Business To Teva (TEVA) 8/3/2016
MEDA Shareholders Representing Approximately 94% Of Meda Shares Accept Mylan (MYL) Offer 8/2/2016
Meda Aktiebolag Applies For Delisting And Convenes An Extraordinary General Meeting 8/2/2016
Extraordinary General Meeting Of Meda Aktiebolag 8/2/2016
Effects Of Brexit On Pharma And The Biotech Industry 8/1/2016
Galapagos (GLPG.BR) Receives Transparency Notification From Federated 8/1/2016
China Cord Blood Files Its Annual Report On Form 20-F 7/29/2016
Resverlogix (RVX.TO) Files 2016 Year-End Disclosure Documents 7/28/2016
Onxeo Reports First-Half 2016 Business Update And Consolidated Financials 7/28/2016
BioPharm Executive: Could It Get Any Worse? 7/27/2016
Week In Review: Cross-Border Investments Rule The News 7/25/2016
Teva (TEVA) Announces Pricing Of Additional CHF1.0 Billion Of Senior Notes In Connection With Pending Acquisition Of Actavis Generics 7/22/2016
Teva (TEVA) Announces Pricing Of Additional €4.0 Billion Of Senior Notes In Connection With Pending Acquisition Of Actavis Generics 7/21/2016
Cormorant Asset Management, LLC Notifies 5.81% Shareholding In TiGenix 7/20/2016
Shrinking Pools Of Money, Depleting Talent May Bind Biotechs After Brexit 7/19/2016
Veritas Pharma Inc Provides Investor Update 7/18/2016
Valeant (VRX) Comments On Recent Stock Transactions 7/14/2016
GW Pharma (GWPH) Announces Proposed Public Offering Of ADSs 7/13/2016
This Neglected Big Pharma Stock Could be About to Explode 7/11/2016
DelMar Pharma Announces Approval For Listing On NASDAQ 7/11/2016
Laborie Medical Technologies Completes Strategic Investment In Medi-Tate Ltd. 7/7/2016
Kitov (KTOV) Announces Closing Of A $12 Million Follow-On Public Offering In The U.S.A. 7/6/2016
Special Committee Of Cipher Pharma (DND.TO) Responds To Early Warning Report Filed By 1207407 Ontario Limited 7/6/2016
Special Committee Of Cipher Pharma (DND.TO) Responds To Early Warning Report Filed By 1207407 Ontario Limited 7/6/2016
Neovasc (NVC) Receives NASDAQ Notification Regarding Minimum Bid Requirements 7/6/2016
Merus (MRUS) Announces Reduced Leverage And Provides Business Update 7/5/2016
ProMis Neurosciences Announces Results Of Annual Meeting Of Shareholders 7/5/2016
3 Biopharma Stocks That Have Taken a Lickin & Kept on Tickin 7/1/2016
Ortho Regenerative Technologies Inc. Grants Options And Appoints New CFO 7/1/2016
Change In Number Of Shares In Wilson Therapeutics 6/30/2016
How Worried Should Intuitive Surgical (ISRG) Shareholders Be About Brexit? 6/30/2016
Kitov (KTOV) Announces Pricing Of $12 Million Follow-On Public Offering In The U.S.A. 6/29/2016
How Brexit Is Affecting UK’s Drug Companies, Including GlaxoSmithKline (GSK), Gilead (GILD) and AstraZeneca PLC (AZN) 6/28/2016
Owlstone Medical Closes $7M (£4.9M) Investment To Commercialize Disease Breathalyzer 6/28/2016
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK), Novartis AG (NVS) and Roche (RHHBY) React to Brexit and Its Possible Impact on Biotech 6/27/2016
400 Jobs Predicted as Canadian Government Sinks $3 Million into Making Sarnia a World Leader in Biotech 6/27/2016
J.P. Morgan Gives Some Love to 3 Battered Specialty Pharma Stocks 6/27/2016
VMS Rehab Systems Eyes Anomaly In Stock Price 6/27/2016
Cardiome Pharma Corp. (COM.TO) Announces Voting Results 6/24/2016
Innocoll (INNL) Announces Closing Of Public Offering 6/23/2016
Acerus (TRLPF) Announces Voting Results For The 2016 Annual General Meeting 6/21/2016
3 Big Pharmas Investors Should Take a Look At 6/20/2016
4 Movers & Shakers in This Year’s Oncology Market 6/20/2016
Kit Check Closes $15 Million Series C Round 6/20/2016
Medivir (MVRBF) Mulls Over Possible Corporate Split and Separate Listing of Commercial Operations 6/15/2016
Resolutions Of The Annual General Meeting Of Evotec AG (EVTG.F) 6/14/2016
Innocoll (INNL) Announces Proposed Public Offering Of Ordinary Shares 6/14/2016
5 Biotech Stocks for Investors Who Want Long-Term Returns 6/13/2016
Ablynx (ABLYF) Release: Publication In Accordance With Article 15 Of The Belgian Law Of 2 May 2007 On The Publication Of Major Shareholdings (The "Transparency Law") 6/13/2016
Biotie Announces That The Delisting Of Its American Depositary Shares From NASDAQ Global Select Market Has Become Effective 6/13/2016
MediGene AG (MDGEF.PK): Notice To The Holders Of The Zero Coupon Convertible Bond 2014/2016 (The "Notes") Of Medigene AG (The "Issuer") 6/10/2016
Trustee Appointed For The Redemption Proceedings Concerning Biotie's Minority Shares 6/10/2016
Company Profile For Mach 7 Technologies 6/10/2016
Galapagos (GLPG.BR) Selected For AEX Index 6/9/2016
Resverlogix (RVX.TO) Announces Corporate Update Webcast 6/9/2016
QIAGEN N.V. (QGEN) Changes Offer Conditions For Acquisition Of Shares In Exiqon A/S 6/9/2016
Scale, Innovation Leadership And Transformation In Focus At Elekta’s Capital Markets Day 6/9/2016
Uscom Limited Oversubscribed PP For Strategic Investment 6/8/2016
VMS Rehab Systems's Generic Drug Unit Launches First Private Placement Of Class 'A' Shares 6/8/2016
3 Bargain Pharma Stocks to Watch 6/7/2016
Prima Biomed (PRR.AX) To Maintain NASDAQ Listing 6/7/2016
GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Kyowa Hakko Kirin, Merck & Co. (MRK), Mitsubishi Tanabe, Nipro Corporation, Sumitomo Dainippon Pharma Co., Ltd. And Salesforce.Com 6/6/2016
Medtronic (MDT) Outlines Future Growth Vision At Investor Day 6/6/2016
Manitex Capital Inc. Completes Dividend-In-Kind Of Shares Of Ortho Regenerative Technologies Inc. 6/6/2016
Valeant (VRX) Receives Additional Notice Of Default Under Indentures Due To Delayed Form 10-Q Filing 6/3/2016
China Biologic Products Announces Secondary Offering Of Common Stock 6/3/2016
Transition Therapeutics (TTH.TO) Receives Notification From NASDAQ 6/3/2016
Galapagos (GLPG.BR) Creates New Warrant Plan 6/2/2016
NeuroVive (NVP) Share Upgraded To OTC Markets Group – OTCQX Best Market In The U.S. 6/2/2016
Activist Investor Carl Icahn's Big Buy of Allergan (AGN) Shares Raises Questions of Influence 6/1/2016
2 Potentially Hot Biotech Stocks Currently Under $5 Per Share 6/1/2016
Mylan (MYL) Announces Pricing of Senior Notes 6/1/2016
Merus (MRUS) Announces Closing Of Partial Exercise Of Underwriters' Over-Allotment Option 5/31/2016
Change Of The Number Of Shares And Votes In Karo Pharma 5/31/2016
BioGaia: Rights Issue in IBT Fully Subscribed – BioGaia’s Underwriting Guarantee Will Not Be Utilized 5/26/2016
Iceni Launches as New Company 5/25/2016
ProMetic Life Sci (PFSCF.PK) Announces Closing Of $60 Million Bought Deal Offering Of Common Shares 5/25/2016
Resolutions From Swedish Orphan Biovitrum AB’s (Sobi) Annual General Meeting (AGM) 5/25/2016
Novartis AG (NVS)'s Pharma Head Exits as Drug Business is Split into Two 5/24/2016
Motif Bio plc Release: Investor Presentation 5/24/2016
10 Biotech Stocks Analysts are Upbeat About in May 5/23/2016
Merus Labs International Inc. Announces Deemed Exercise Of Special Warrants 5/19/2016
DelMar Pharma Announces Reverse Stock Split In Preparation For Proposed Senior Exchange Uplisting 5/19/2016
GeneNews (GEN.TO) Announces A Further Extension Of The TSX’s Remedial Review Process 5/19/2016
Nordic Nanovector: Annual General Meeting Held 5/19/2016
QIAGEN N.V. (QGEN) Extends Tender Offer Period For Acquisition Of Exiqon A/S 5/19/2016
Biotie To Delist Its American Depositary Shares From The Nasdaq Global Select Market 5/18/2016
Biotie Cancels All Treasury Shares Held By The Company 5/18/2016
Biotie To Delist Its Ads From The Nasdaq Global Select Market 5/18/2016
Galapagos (GLPG.BR) Release: Listing Of Existing Shares On Euronext Brussels & Amsterdam 5/17/2016
Bulletin From Annual General Meeting Of SciBase Holding AB (publ) On 16 May 2016 5/17/2016
Thomson Reuters: China Leads the World In Pharmaceutical Innovation 5/16/2016
Nordic Nanovector: Proposal From The Nomination Committee To The Annual General Meeting 19 May 2016 5/13/2016
Annual General Meeting 2016 In Karo Pharma AB (publ) 5/13/2016
ThromboGenics NV (TBGNF) Business Update - Q1 2016 5/13/2016
Allergan (AGN) Reworking Its Executive Team, Outlines $10 Billion Stock Buyback as Q1 Revenue Falls Short 5/12/2016
Sophiris Bio (SPHS) Announces Closing Of Public Offering of $5,000,000 5/12/2016
Resolutions Adopted At The Annual General Meeting Of Hansa Medical 5/12/2016
Despite Investor Pressure, GlaxoSmithKline (GSK) is Not Considering a Breakup 5/9/2016
Sophiris Bio (SPHS) To Raise Approximately $5 Million Through At-the-Market Offering 5/9/2016
Valeant (VRX) Announces Expected Timing Of Form 10-Q Filing And Reiterates 2016 First Quarter Guidance 5/9/2016
BioInvent (BOVNF)’s Board Director Dharminder Chahal Increases His Shareholding In The Company 5/6/2016
DelMar Pharma Announces $5.6 Million Private Placement Of Preferred Shares 5/5/2016
NeuroDerm (NDRM) Announces 2016 Annual General Meeting Of Shareholders 5/5/2016
Siemens Healthcare (SI) Rebrands as the "Healthineers" 5/5/2016
ProMis Neurosciences Successfully Completes CDN $1.0 Million Private Placement 5/4/2016
Oncolytics Biotech Inc. (ONC.TO) Announces Details Of 2016 Annual Meeting Of Shareholders 5/3/2016
Resolutions At The Annual General Meeting In Medivir (MVRBF) On 3 May 2016 5/3/2016
Theravance Biopharma (TBPH) Announces Pricing Of Public Offering Of Its Ordinary Shares 5/2/2016
Change In Number Of Shares And Votes In Addlife AB 4/29/2016
DBV Tech Announces Filing Of 2015 "Document de Référence" And 2015 Annual Report On Form 20-F 4/29/2016
Resolutions At The Annual General Meeting In Biotage AB (BIOTa.ST) On April 28, 2016 4/29/2016
Theravance Biopharma (TBPH) Announces Proposed Public Offering Of Its Ordinary Shares 4/29/2016
Tiziana Life Sciences Plc Announces Exercise Of Warrants & Issue Of Equity 4/29/2016
Motif Bio plc Release: Amphion Innovations plc 4/28/2016
Dehaier Medical (DHRM) Receives US$20 Million Strategic Investment From Liaison Interactive 4/28/2016
BioAmber Inc. Secures CAD$10 Million Loan From BDC For Sarnia Plant 4/27/2016
Veritas Pharma Inc - Private Placement Offering 4/27/2016
Sinovac Biotech Ltd. (SVA) Files 2015 Annual Report On Form 20-F 4/26/2016
MabPlex Launches New English Website 4/26/2016
Valeant (VRX) Receives Additional Notices Of Default Under Indentures Due To Delayed 10-K Filing 4/25/2016
Adaptimmune (ADAP) Presents Corporate And Clinical Updates At Investor And Analyst Day 4/25/2016
Perrigo (PRGO) Responds To Market Rumors 4/22/2016
Basilea (BSLN.SW) Shareholders Approve All Resolutions Proposed By The Board Of Directors At The Ordinary General Meeting Of Shareholders 4/21/2016
Aralez Announces Several Corporate Updates 4/20/2016
Rocky Times for Novartis AG (NVS) as CEO Faces Battle to Restore Confidence in Investors 4/19/2016
Silence Therapeutics Release: Director’s Dealings 4/19/2016
Boehringer Ingelheim Reports A Successful Financial Year 2015 4/19/2016
QIAGEN N.V. (QGEN) Publishes Offer Document In Connection With The Conditional Voluntary Takeover Offer For The Shares In Exiqon A/S 4/19/2016
DiagnoCure (CUR) Announces Its Decision To Proceed With The Voluntary Liquidation And Dissolution Of The Corporation 4/18/2016
Meda AB (MEDA-A.ST) (publ) AGM Bulletin 4/15/2016
Valeant (VRX) Provides Update Regarding Regulatory Matters 4/14/2016
Hutchison China MediTech (Chi-Med) Announces Exercise Of Overallotment Option 4/13/2016
Notice Of The Annual General Meeting Of The Shareholders In SciBase Holding AB 4/13/2016
Macrocure (MCUR) Announces Receipt Of NASDAQ Minimum Bid Price Notification 4/11/2016
Immune Therapeutics Provides Drug Development Program Status Update On Methionine-Enkelphine ("MENK") In China 4/11/2016